Rachel Seidman

500 total citations
8 papers, 445 citations indexed

About

Rachel Seidman is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Rachel Seidman has authored 8 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 5 papers in Immunology and 2 papers in Molecular Biology. Recurrent topics in Rachel Seidman's work include Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (2 papers). Rachel Seidman is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (3 papers) and CAR-T cell therapy research (2 papers). Rachel Seidman collaborates with scholars based in Israel, United States and Australia. Rachel Seidman's co-authors include Marina Wolfson, Orli Sagi, Inna Gitelman, Susan Band Horwitz, Michal J. Besser, Avraham J. Treves, Gal Markel, Rivka Ofir, Yacob Weinstein and Margalit Krup and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Infection and Immunity.

In The Last Decade

Rachel Seidman

8 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel Seidman Israel	8	199	197	133	71	47	8	445
Ju-Yu Hsu Taiwan	8	186 0.9×	311 1.6×	103 0.8×	29 0.4×	168 3.6×	11	605
Jüri Habicht Germany	10	39 0.2×	207 1.1×	295 2.2×	70 1.0×	47 1.0×	18	515
Bin Kan China	9	103 0.5×	230 1.2×	160 1.2×	33 0.5×	26 0.6×	13	370
Jeroen Bakker Netherlands	9	72 0.4×	237 1.2×	109 0.8×	19 0.3×	155 3.3×	12	518
Bernadette Barbarat France	11	88 0.4×	122 0.6×	240 1.8×	10 0.1×	35 0.7×	15	451
Koji Hayashizaki Japan	12	97 0.5×	148 0.8×	351 2.6×	31 0.4×	14 0.3×	16	512
Ute Henseleit Germany	8	44 0.2×	159 0.8×	115 0.9×	22 0.3×	17 0.4×	10	354
S Nakagawa Japan	16	236 1.2×	404 2.1×	320 2.4×	71 1.0×	16 0.3×	26	702
R P Mischak United States	9	229 1.2×	209 1.1×	253 1.9×	237 3.3×	14 0.3×	12	605

Countries citing papers authored by Rachel Seidman

Since Specialization

Citations

This map shows the geographic impact of Rachel Seidman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Seidman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Seidman more than expected).

Fields of papers citing papers by Rachel Seidman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Seidman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Seidman. The network helps show where Rachel Seidman may publish in the future.

Co-authorship network of co-authors of Rachel Seidman

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Seidman. A scholar is included among the top collaborators of Rachel Seidman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Seidman. Rachel Seidman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Markel, Gal, Michal J. Besser, Kfir Oved, et al.. (2009). Preclinical evaluation of adoptive cell therapy for patients with metastatic renal cell carcinoma.. PubMed. 29(1). 145–54. 33 indexed citations

2.

Markel, Gal, Rachel Seidman, Michal J. Besser, et al.. (2009). Natural Killer Lysis Receptor (NKLR)/NKLR-Ligand Matching as a Novel Approach for Enhancing Anti-Tumor Activity of Allogeneic NK Cells. PLoS ONE. 4(5). e5597–e5597. 21 indexed citations

3.

Markel, Gal, Rona Ortenberg, Rachel Seidman, et al.. (2009). Systemic dysregulation of CEACAM1 in melanoma patients. Cancer Immunology Immunotherapy. 59(2). 215–230. 53 indexed citations

4.

Markel, Gal, Rachel Seidman, Yifat Cohen, et al.. (2008). Dynamic expression of protective CEACAM1 on melanoma cells during specific immune attack. Immunology. 126(2). 186–200. 42 indexed citations

5.

Markel, Gal, Rachel Seidman, Gil Katz, et al.. (2006). Inhibition of Human Tumor-Infiltrating Lymphocyte Effector Functions by the Homophilic Carcinoembryonic Cell Adhesion Molecule 1 Interactions. The Journal of Immunology. 177(9). 6062–6071. 49 indexed citations

6.

Ofir, Rivka, Rachel Seidman, Margalit Krup, et al.. (2002). Taxol-induced apoptosis in human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3 and caspase-9 independent. Cell Death and Differentiation. 9(6). 636–642. 113 indexed citations

7.

Seidman, Rachel, Inna Gitelman, Orli Sagi, Susan Band Horwitz, & Marina Wolfson. (2001). The Role of ERK 1/2 and p38 MAP-Kinase Pathways in Taxol-Induced Apoptosis in Human Ovarian Carcinoma Cells. Experimental Cell Research. 268(1). 84–92. 92 indexed citations

8.

García‐Moncó, Juan Carlos, Rachel Seidman, & Jorge L. Benach. (1995). Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides. Infection and Immunity. 63(10). 4130–4137. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact